Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07374315 · ClinicalTrials.gov registry record · NA

Weight Gain in Pediatric Leukemia Survivors

A NA study, sponsored by Washington University School of Medicine.

Not yet
Registry status
NA
Development phase
80
Enrollment target

NCT07374315: Clinical Trial NA study, sponsored by Washington University School of Medicine.

NCT07374315 is a NA study that has not yet begun recruiting, run by Washington University School of Medicine. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07374315, a NA study, has not yet begun recruiting, sponsored by Washington University School of Medicine.

NOT YET RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target

Study Summary

This is a trial assessing the efficacy of two weight maintenance programs for children with acute lymphoblastic leukemia (ALL) and the patients' caregivers. Patients and their caregivers will be randomized 1:1 to Arm A, a non-intensive educational intervention using National Institute of Health (NIH) Educational Resources (We Can! for children 8-13 and Take Charge of Your Health for teenagers 14-18), or Arm B, a Modified Guided Self-Help Family Intervention for Leukemia patients (mL-GSH). Outcomes will be assessed through activity trackers, obesity biometrics, and nutrition and physical activity assessments.

Primary Outcome

Participant's weight Z score is a statistical value that indicates how the participant's weight for their age and sex compares to the average weight for that population which is obtained from Center for Disease Control (CDC) growth Charts

Interventions

  • BEHAVIORAL Modified Guided Self-Help Family Intervention
  • BEHAVIORAL NIH Educational Resources
  • BEHAVIORAL FitBit Ace
  • BEHAVIORAL WashU Extended Learning Canvas

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2026-05-31
Est. Completion 2029-02-28
Phase NA

What is known before NCT07374315 opens enrollment

NCT07374315 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 4 interventions - of which Modified Guided Self-Help Family Intervention is the first listed.

NCT07374315 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07374315 about?

NCT07374315 is a clinical study titled "Weight Gain in Pediatric Leukemia Survivors". This is a trial assessing the efficacy of two weight maintenance programs for children with acute lymphoblastic leukemia (ALL) and the patients' caregivers. Patients and their caregivers will be randomized 1:1 to Arm A, a non-intensive educational intervention using National Institute of Health (NIH...

What is the current status of trial NCT07374315?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-05-31. Estimated completion is 2029-02-28.

What interventions are being tested in trial NCT07374315?

The interventions under investigation include: Modified Guided Self-Help Family Intervention (BEHAVIORAL), NIH Educational Resources (BEHAVIORAL), FitBit Ace (BEHAVIORAL), WashU Extended Learning Canvas (BEHAVIORAL).

Who is sponsoring clinical trial NCT07374315?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07374315's enrollment target sits among peer trials

80 994th of 2000 higher than 941 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07374315, the US trial registry maintained by the National Library of Medicine. NCT07374315 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.